Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
800,025
-
Share change
-
-20,735
-
Total reported value
-
$112,644,749
-
Put/Call ratio
-
88%
-
Price per share
-
$140.78
-
Number of holders
-
103
-
Value change
-
-$3,045,181
-
Number of buys
-
27
-
Number of sells
-
41
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2022
As of 30 Sep 2022,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
800,025 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, MOGY JOEL R INVESTMENT COUNSEL INC, LPL Financial LLC, UBS Group AG, PEAPACK GLADSTONE FINANCIAL CORP, ROYAL BANK OF CANADA, and Conservest Capital Advisors, Inc..
This page lists
103
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.